Cardinal Health extends CVS deal. Cardinal Health stock costs EUR 226.20 not valid? wait

Published on 10/16/2026 at 10:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health reaffirmed USD 12.40-12.60 adjusted EPS guidance on October 1, 2026. Cardinal Health stock costs EUR 226.20 on October 16, 2026.

Contract and earnings dates

Cardinal Health extended its CVS distribution agreement through June 30, 2032, on October 1, 2026.
Fiscal year 2027 adjusted earnings per share guidance remained USD 12.40-12.60.
Cardinal Health stock was trading at EUR 226.20 at 10:18 a.m. CEST on October 16, 2026.

Geometrisches Bauhaus-Poster mit Text PHARMA DISTRIBUTION in Rot und Schwarz — Bauhaus-Poster für Cardinal Health Inc. zeigt geometrische Pharma-Distribution-Grafik – NYSE ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) was trading at EUR 226.20 at Lang & Schwarz on October 16, 2026 at 10:18 a.m. CEST. The company had extended its pharmaceutical distribution agreements with CVS Health through June 30, 2032, while reaffirming its fiscal year 2027 adjusted earnings per share guidance.

CVS agreement runs to 2032

According to the SEC filing dated October 1, 2026, Cardinal Health entered a binding letter of intent to extend the existing CVS distribution agreements through June 30, 2032. The filing says the arrangement preserves the current scope of distribution services.

The renewal gives the pharmaceutical distribution business a defined customer horizon of more than five years from the announcement date. Cardinal Health also reaffirmed long-term adjusted earnings per share growth guidance of 12 percent to 14 percent in the same filing.

What does guidance imply?

Fiscal year 2027 adjusted earnings per share guidance stands at USD 12.40 to USD 12.60, a range that StockTitan reports as 13 percent to 15 percent growth based on adjusted fiscal year 2026 results. The comparison excludes the fiscal year 2026 benefit from an IEEPA tariff refund.

Three dates define the setup

On August 11, 2026, Cardinal Health reported quarterly adjusted earnings per share of USD 2.91 and revenue of USD 63.67 billion, according to MarketBeat. On October 1, 2026, the CVS extension and the USD 12.40-12.60 guidance range were announced. On October 15, 2026, Cardinal Health paid a quarterly dividend of USD 0.5158 per share.

Next reporting date

Cardinal Health is scheduled to release first-quarter fiscal year 2027 results on November 5, 2026, before the New York Stock Exchange opens, according to Cardinal Health. The release will provide the next test of the guidance range and the CVS contract outlook.